FDA approves Depomed's urinary tract treatment
home > blogdigger
Specialty drugmaker Depomed Inc. Friday said the U.S. Food and Drug Administration approved its extended-release antibiotic Proquin XR as a treatment for urinary tract infections, making it the company's first approved product. The once-daily, extended-release formulation of ciprofloxacin hydrochloride is the first version of Bayer's antibiotic Cipro to list nausea and...
- link to FDA approves Depomed's urinary tract treatment -
Last update: 06/01/2005